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ABSTRACT
Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizing 
local drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. The 
device is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatment 
regimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study was 
to describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment.
Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selected 
for the study. The dogs were randomly allocated to two groups with five and six animals, and each group received the 
chemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were made 
whenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the Madison-
Wisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia, 
using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions were 
compared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1); 
immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). The 
arithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean of 
SBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2 
and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC group. The handling time 
of VAP group was 110.6 ± 8.4 s, compared to 219.2 ± 24.7 s (mean ± standard error) in the PVC group, showing statisti-
cally significant difference (P < 0.001). VAP surgical implantation time averaged 37 min, decreasing gradually from the 
first (55 min) to the last patient (21 min). 
Discussion: SBP levels suggest that the VAP group was calmer from the beginning to the end of the sessions, showed 
lower SBP levels, and required shorter handling time than did the PVC group. Blood pressure is one of the most objec-
tive ways to assess welfare or stress in dogs. When dog feels threatened or scared, its body automatically enters a state of 
emergency and, among several changes, blood pressure increases. VAP surgical implantation in dogs have easy learning, 
as previously described, proven by implantation time progressive reduction. The Seldinger technique is the method of 
choice for catheter implantation in humans. Dissection of the jugular vein is an alternative, however, the technique with 
a single incision and venipuncture is less invasive than its modifications. The jugular vein was used because is the site of 
choice for central accesses in veterinary practice, with a shorter path to the right atrium and smaller rates of catheter mis-
placement, reducing the risk of pneumothorax, venous thrombosis, and pinch-off syndrome. VAP surgical implantation in 
dogs have easy learning, proven by the implantation time progressive reduction. The study confirmed that VAP promoted 
animal welfare, shortened chemotherapy sessions, and caused less discomfort to dogs treated for multicentric lymphoma, 
as indicated by the reduction in SBP, when compared to the PVC group.
Keywords: antineoplastic therapy, canine, oncology, port-a-cath.
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INTRODUCTION
Multicentric lymphoma accounts for approxi-
mately 50% of cases of canine lymphoma [7], and 
the Madison-Wisconsin protocol, is a chemotherapy 
conducted for a long time period, until remission and/
or survival [6]. Intravenous drugs used cause necrosis 
and detachment of the subcutaneous tissue in case of 
extravasation, requiring constant monitoring of the 
patient during their application [30].
Vascular access port (VAP) was developed 
for the administration of chemotherapeutic agents, 
minimizing local drug reactions and complications 
associated with migration of peripheral venous 
catheter (PVC) in humans [9]. The device is widely 
used in human oncology and has gained importance 
in veterinary oncology as well, especially in long 
treatment regimens, as in the case of lymphoma 
[16]. VAP favors therapy and the animals’ quality 
of life [24]. 
Utilization of VAP is not a regular practice 
and is not commonly investigated in the veterinary 
medicine literature [18]. It is suggested that the device 
reduces the discomfort caused by PVC, promoting 
animal welfare with multicentric lymphoma during the 
long treatment regimen [14]. The aim of this study was 
to describe the use of VAP in dogs, comparing to PVC 
access, during canine lymphoma chemotherapeutic 
treatment.
MATERIALS AND METHODS
Selection of animals
Eleven dogs with multicentric lymphoma 
treated with chemotherapy at the Veterinary Teaching 
Hospital were included in the study. The dogs were 
male or female, of different breeds, weights, and ages, 
no aggressive behavior, were not on antihypertensive 
medication and without heart disease, discarded on 
electrocardiogram and echocardiogram. Before than 
start chemotherapeutic treatment, the dogs were 
randomly allocated to two groups with five and six 
animals, and each group received the chemotherapy 
protocol through the PVC (n= 5) or VAP (n= 6). For 
the sake of standardization, assessments were made 
whenever the dogs received vincristine sulfate1, de-
spite the use of the infusion system in all sessions 
of the Madison-Wisconsin protocol, which lasted 
25 weeks. 
Methodology
A VAP was implanted into the right external 
jugular vein of six dogs under inhalational anesthesia. 
The dogs received preoperative intravenous antibiotic 
prophylaxis with sodium ampicillin2 (22 mg.kg-1) 
and were then placed on left lateral decubitus with 
the right thoracic limb caudally. Catheter length was 
estimated, and it should reach the fourth rib region, 
at the junction of the cranial vena cava with the right 
atrium. Hair was shaved and antisepsis were per-
formed at ventral and lateral neck. An anesthetic block 
was made with lidocaine hydrochloride3 (4 mg.kg-1) 
in the skin incision area where the catheter reservoir 
would be inserted.
VAP implantation was timed since percutane-
ous puncture until last skin suture. BardPort M.R.I.® 
Hard Base Port (6.6 French)4, a plastic single lumen, 
open-ended catheter of radiopaque silicone, was the 
VAP used. The Seldinger implantation technique was 
performed always by the same surgeon. The procedure 
started with percutaneous puncture of the jugular vein 
in blood flow direction, in the region between the man-
dibular angle and the manubrium, using a needle and 
a 10-mL syringe containing 5 mL of sodium chloride5 
(NaCl 0.9%) [Figure 1A], provided with implantation 
kit. A metal guidewire was advanced through needle 
until it reached the vessel lumen, and the needle was 
removed (Figure 1B). A specific dilator from the kit 
was inserted up to the jugular vein (Figure 1C), which 
was dilated, permitting the removal of the guidewire 
and catheter insertion through the dilator. After the 
catheter insertion into the blood vessel, the dilator 
was split apart and removed (Figure 1D). Thereafter, 
a semilunar skin incision was made 5 cm above the 
puncture site in the medial dorsal neck region (Fig-
ure 1E) for placement of the catheter reservoir. The 
catheter was then advanced through the subcutaneous 
tissue to the incision area using the tunneler equipment 
provided with the implantation kit (Figure 1F & 1G) 
and connected to the reservoir. The reservoir was then 
attached to the muscle fascia below the incision with 
mononylon (3-0)6 threads through the holes (Figure 
1H). The system functionality was tested by aspirating 
blood with a 10-mL syringe through the Huber7 needle 
connected to the reservoir. The skin was sutured over 
the reservoir with mononylon 3-06 threads (Figure 
1I). The catheter was flushed with heparin sodium3 
(100 IU.mL-1). 
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The dogs were discharged on sodium dipyrone8 
(25 mg.kg-1, every 8 h for three days) and the own-
ers were instructed to cleanse the stitches with NaCl 
0.9%5 until their removal at 10 days. Two days after 
implantation, the dogs were ready for chemotherapy, 
but assessments began only after the stitches were 
removed, to not interfere in needle fixation.
Hair was shaved and antisepsis of reservoir 
region was performed before the infusion of chemo-
therapeutic drugs. A Huber needle7 (20 G and 20 mm) 
and a 10-mL syringe were used whenever the VAP 
reservoir was punctured. The owner restrained the 
animal during all the procedure. The Huber needle7 
was inserted into the reservoir, and aspiration with a 
syringe was performed to confirm the proper operation 
of VAP through blood return. 
Chemotherapy protocol
The chemotherapeutic agent was administered 
via a NaCl 0.9%5 infusion system connected to VAP. 
The patients were kept on NaCl 0.9%5 until approxi-
mately 20 mL was infused, thus eliminating any resi-
dues of the chemotherapeutic agent from the catheter. 
After that, the catheter was flushed with heparin - see 
manufacturer’s values (0.6 mL for the reservoir plus 
0.01 mL for each centimeter of the catheter), and the 
Huber needle7 was removed. The VAP was handled 
always by the same veterinarian.
The remaining five dogs received conventional 
chemotherapeutic treatment. In all sessions, the dogs 
were physically restrained by an assistant. Hair was 
shaved and antisepsis of right or left thoracic limb 
was performed, in cranial radio and ulna region. Af-
terwards, the cephalic vein was punctured for PVC 
placement (Radiopaque Safelet catheter)9, with manual 
tourniquet applied in the limb by the assistance. The 
catheter gauge depended of the dog size. The venipunc-
ture was performed always by the same veterinarian. 
The chemotherapeutic agent was administered using 
a NaCl 0.9%5 infusion system connected to the PVC, 
removed at the end of the infusion.
Figure 1. Vascular access port implantation in a dog (skull shown on the right side). A- Jugular vein puncture with needle and syringe, in blood flow 
direction. B- Insertion of guidewire into the blood vessel. C- Dilation of tissues with specific tool. D- Placement of catheter and removal of dilator. E- 
Semilunar skin incision for catheter reservoir placement. F- Insertion of tunneler towards the skin incision. G- Advancement of the catheter connected 
to the tunneler through the subcutaneous tissue. H- Attachment of the reservoir to the neck musculature. I- Skin suture and final aspect.
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Noninvasive systolic blood pressure (SBP) 
was checked in both groups (doppler vascular10 and 
aneroid sphygmomanometer11) in three time period 
during procedures: 10 min after arrival to each che-
motherapy (P1); immediately after placement of the 
PVC or puncture of the VAP reservoir (P2); and at 
the end of chemotherapy (P3). The arithmetic mean 
of five consecutive assessments was used in each 
time period. To compare SBP assessments of each 
dog, the percent variation in blood pressure levels 
between P1 and P2 and P1 and P3 was calculated 
using the formula: [(P2-P1)/P1]*100 and [(P3-P1)/
P1]*100.
Handling time during each session was re-
corded, not including SBP assessments and infusion of 
the chemotherapeutic drug. The patients were assessed 
for 60 days in three chemotherapy sessions (S1, S2, 
and S3). At the end of the treatment protocol, VAP was 
maintained in place, as owner’s option, and the dogs 
returned for heparinization every four weeks.
Statistical analysis
The statistical analysis was performed using 
IBM SPSS version 2212 SBP and handling time were 
denoted as mean and standard error and compared by 
generalized estimating equations (GEEs). The signifi-
cance level was set at 0.05.
RESULTS
In the chemotherapy sessions, the mean of SBP 
variation decreased statistically significant in the VAP 
group compared to PVC group. SBP decreased from P1 
to P2 and from P1 to P3 in all sessions (S1, S2, and S3) 
in the VAP group, and increased in the PVC group. Only 
SBP from P1 to P3 in S2 was not statistically significant 
between the two groups (Figure 2). The handling time 
of VAP group was 110.6 ± 8.4 s, compared to 219.2 ± 
24.7 s (mean ± standard error) in the PVC group, show-
ing statistically significant difference (P < 0.001). The 
larger handling time in the PVC group resulted from 
the difficulty in puncturing the vein and positioning the 
catheter in the frequent vascular accesses.
VAP implantation time averaged 37 min, de-
creasing gradually from the first (55 min) to the last 
patient (21 min). All VAP were implanted using the 
Seldinger technique. A 6.6 French catheter was chosen, 
and its use was slightly difficult in smaller animals 
because of venous lumen diameter.
Estimating the length of the VAP to be inserted 
was a hindrance, since imaging resources were not 
available in the surgical ward. Positioning was con-
firmed by chest X-ray only at the time of stitch removal.
Figure 2. Systolic blood pressure (SBP) variation in dogs subjected to chemotherapy through vascular access port (VAP) or peripheral venous catheter 
(PVC). The boxes represent the mean percentage of SBP variation in different sessions (S1 - white, S2 - black, S3 - gray) and in the groups (VAP and 
PVC). Vertical bars indicate standard errors. A- Variation between P1 (rest) and P2 (after venipuncture). Groups followed by * are statistically different 
according to GEE: P = 0.047 in S1, P = 0.002 in S2, and P < 0.001 in S3. B- Variation between P1 (rest) and P3 (end of chemotherapy). Groups followed 
by * are statistically different according to GEE: P = 0.008 in S1 and P < 0.001 in S3.
In the smallest dog (6.2 kg), VAP was long and 
reached the caudal vena cava, without any complica-
tions in echocardiogram and electrocardiogram.
The largest three dogs (13.5, 25 and 26 
kg) had thick skin and developed seroma around 
the VAP reservoir. Two dogs did not have any 
relapse after drainage. The dog weighing 13.5 
kg, in which the catheter was advanced along a 
larger subcutaneous path, had major seroma and 
relapse after drainage, and the dead space had to 
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be eliminated with polyglactin 910 (3-0)6 sutures 
on a single plane with single stitches under general 
anesthesia. In the same dog, because of thick skin, 
the reservoir was directed cranial towards the skin 
incision after advancement of the VAP through 
the subcutaneous tissue, as the angle would be too 
acute at the reservoir inlet. Thus, the catheter was 
advanced caudally, with longer subcutaneous tun-
neling. Probably catheter long and seroma resulted 
in catheter looping (Figure 3). 
A dog of VAP group was excluded from SBP 
measuring results, and had the VAP removed, because of 
subcutaneous catheter tip migration 24 days after implan-
tation and after two chemotherapy sessions. The catheter 
length estimate at implant procedure was inaccurate and 
the catheter did not reach the correct site in at the junc-
tion of the cranial vena cava with the right atrium (Figure 
4A). The problem was detected when there was no blood 
return through the catheter in third chemotherapy session, 
confirmed by radiography (Figure 4B). 
Figure 3. Plain radiograph (lateral view) of a dog with vascular access port 
(VAP) catheter looping close to the reservoir, in the neck region (arrow).
Figure 4. Plain radiograph (lateral view) of a dog with vascular access port (VAP). A- VAP shorter than would be necessary (arrow); 
B- VAP migration into subcutaneous tissue (arrow).
DISCUSSION
SBP levels suggest that the VAP group was 
calmer from the beginning to the end of the sessions, 
showed lower SBP levels, and required shorter handling 
time than did the PVC group. Blood pressure is one 
of the most objective ways to assess welfare or stress 
in dogs [31]. When dog feels threatened or scared, its 
body automatically enters a state of emergency and, 
among several changes, blood pressure increases [22]. 
SBP is also influenced by stress and anxiety during 
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veterinary care (“white-coat syndrome”) [28], but this 
may be minimized with VAP. It may be also inferred 
that VAP reduced pain, although to a lesser extent, 
caused by venipuncture, increasing the circulating 
levels of catecholamines and, consequently, of blood 
pressure [23]. This study, to some extent, assessed 
the discomfort of animals caused by venipunctures 
and demonstrated the VAP benefits for pain relief and 
reduction patient discomfort in repeated venipunctures 
[14]. Another factor that might have contributed to 
lower SBP in the VAP group, compared to the PVC 
group, was restraint by the owners that keeping the 
dogs comfortable and reducing their stress [27]. Our 
results suggest that the VAP could be an alternative for 
stressed and aggressive animals or those of difficult 
containment.
VAP surgical implantation in dogs have easy 
learning, as previously described [24], proven by im-
plantation time progressive reduction. The Seldinger 
technique is the method of choice for catheter implanta-
tion in humans; in addition, it is less time-consuming 
and has a higher success rate at the first attempt [19], 
even in smaller animals, since there is no correlation 
between a successful implantation and weight of the 
patients [1]. Dissection of the jugular vein is an alter-
native, as in the experiment that used #5 and 7 French 
catheters for animals weighing up to 15 kg and over 
15 kg, respectively [14]. However, the technique used, 
with a single incision and venipuncture, is less invasive 
than its modifications [14]. The jugular vein was used 
because is the site of choice for central accesses in vet-
erinary practice, with a shorter path to the right atrium 
and smaller rates of catheter misplacement, reducing 
the risk of pneumothorax, venous thrombosis, and 
pinch-off syndrome [17]. Previous studies have used 
the jugular vein to placed VAP for chemotherapy in 
dogs [24,29], and also other sites such as the femoral 
vein, left atrium, and aorta [3,5]. 
In our study, catheter length was estimated 
up to the fourth rib, as the VAP should be advanced 
to the level of the right atrium [29]. The chest X-
ray confirmed the position, as indicated [8]. Imag-
ing made by a fluoroscope, electrocardiogram, or 
ultrasound guides the implantation and minimizes 
the risk of catheter misplacement [15], but a study 
did not find any differences between the use of an 
electrocardiogram or the blind technique used herein 
[8]. Catheter misplacement may cause cardiac ar-
rhythmia, cardiac tamponade, phlebitis, hemotho-
rax, sepsis, and even cardiac perforation [8]. These 
complications were not observed, even in the dog 
that VAP reached the caudal vena cava, as a similar 
case previously reported [24].
Seroma is a minor complication described in 
veterinary [11] and human medicine [2,25]. In dogs 
here related the seroma had to be drained, unlike in 
felines, in which the seroma resolved spontaneously 
[2]. Reduction of the dead space is recommended, as 
dogs are prone to seroma development in neck region 
[26], besides the potential to develop atypical and 
aggressive bacterial infection in the seromatous fluid 
[10], which could predispose to VAP contamination. 
Others complications such as edema, hematoma, 
catheter fracture, sepsis, occlusion, self-harm events, 
thromboembolism, extravasation, fistula formation, 
and disconnection of the catheter from the reservoir 
[4,25], were not observed in our study. The maneuver 
performed in the thick-skinned dog prevented the cath-
eter from bending, which could cause obstruction and 
catheter failure [21]. Late migration of VAP into the 
subcutaneous tissue in this study has been described 
in humans [20], but classified as early migration, oc-
curring between two and seven days after implantation 
or until the first chemotherapy session [12]. The dog 
here described was overweight and thin-skinned, fac-
tors that might have contributed to the migration of the 
VAP tip, suggesting non-recommending of the device 
in these cases.
We observed other advantage of VAP as the 
lack of external components that could disturb the 
animal, the prevention of multiples peripheral veins 
punctures, and no worries with catheter management 
by owners during treatment [4,13,26]. Our results 
demonstrated that VAP device was effective in canine 
lymphoma regarding duration of Madison-Wisconsin 
therapy protocol, preserving peripheral vessels [29].
CONCLUSIONS
The study confirmed that VAP promoted 
animal welfare, shortened chemotherapy sessions, and 
caused less discomfort to dogs treated for multicentric 
lymphoma, as indicated by the reduction in SBP, when 
compared to the PVC group. The Seldinger technique is 
feasible for dogs, its complications could be managed 
without any harm to the animals, and its frequent use 
in veterinary medicine should be therefore encouraged.
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